Physiological Performance of Drug‐Coated Balloons in Small Coronary Arteries PICCOLETO II μFR
Catheterization and Cardiovascular Interventions · 2025-02 · 105 (3) · 643-649
DOI: 10.1002/ccd.31376 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 24.12.2024. Verfasst von Simone Fezzi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Cardiology, University of Verona, Verona, Italy. Hauptthemen laut MEDLINE: Angioplasty, Balloon, Coronary, Cardiac Catheters, Cardiovascular Agents, Coated Materials, Biocompatible. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Background
Drug‐coated balloons (DCB) are emerging as an alternative to permanent implants for managing de novo coronary artery disease, particularly in small vessels (SVD). This sub‐analysis of the PICCOLETO II study aimed to compare the performance of DCB and DES in terms of Murray's law‐based quantitative flow ratio (μFR) changes between baseline, post‐percutaneous coronary intervention (PCI), and follow‐up.
Methods
Patients with a clinical indication for PCI were assigned to receive either Xience DES or Elutax SV/Emperor DCB. Coronary angiograms were blindly analyzed by an independent Core Laboratory (Consorzio Futuro in Ricerca, University of Ferrara, Italy).
Results
Among 232 patients, 59 were included in this analysis. Pre‐PCI μFR was comparable between groups (0.65 ± 0.29 vs. 0.58 ± 0.25; p = 0.20). Post‐PCI, the DCB group had a lower acute functional gain compared to DES (+0.21 vs. +0.31; p = 0.064), with lower μFR values (0.86 ± 0.36 vs. 0.89 ± 0.3; p = 0.074). At 6‐month follow‐up, μFR values were similar between groups (0.84 ± 0.29 vs. 0.84 ± 0.31, p = 0.93), with a comparable late functional loss (−0.02 vs. −0.05; p = 0.93). Angiographic late lumen loss was significantly lower in the DCB group (−0.03 vs. +0.29 mm; p = 0.027).
Conclusions
DCB‐based PCI showed a trend toward less favorable immediate post‐PCI functional result but a comparable performance at follow‐up, suggesting its potential in treating de novo SVD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Cardiology, University of Verona, Verona, Italy.
- Cardiovascular Department, Ospedale di Trapani, Trapani, Italy.
- Department of Clinical and Experimental Medicine, Policlinico G. Martino, University of Messina, Messina, Italy.
- Interventional Cardiology, ASST Fatebenefratelli-Sacco, Milano, Italy.
- Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.
- DCB Academy, Milano, Italy.
ORCID-Profile: Simone Fezzi, Bernardo Cortese
Zitieren
APA
Fezzi, S., Trevisanello, A., Buccheri, D., Borgi, M., Orrego, P. S., Zoccai, G. B., & Cortese, B. (2025). Physiological Performance of Drug‐Coated Balloons in Small Coronary Arteries PICCOLETO II μFR. Catheterization and Cardiovascular Interventions, 105(3), 643-649. https://doi.org/10.1002/ccd.31376
Vancouver
Fezzi S, Trevisanello A, Buccheri D, Borgi M, Orrego PS, Zoccai GB, et al. Physiological Performance of Drug‐Coated Balloons in Small Coronary Arteries PICCOLETO II μFR. Catheterization and Cardiovascular Interventions. 2025;105(3):643-649. doi:10.1002/ccd.31376
BibTeX
@article{Fezzi2025,
author = {Fezzi, Simone and Trevisanello, Aurora and Buccheri, Dario and Borgi, Marco and Orrego, Pedro Silva and Zoccai, Giuseppe Biondi and Cortese, Bernardo},
title = {Physiological Performance of Drug‐Coated Balloons in Small Coronary Arteries PICCOLETO II μFR},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
volume = {105},
number = {3},
pages = {643--649},
doi = {10.1002/ccd.31376}
}
EUVIMED